Researcher
Joke De Vocht
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
- See also: Joke De Vocht (Flanders Institute for Biotechnology)
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From9 Oct 2017 → Today - Van Den Bosch Lab (Research group)
Member
From1 Oct 2017 → Today
Projects
1 - 3 of 3
- A multi-modal and longitudinal approach to study the neurobiological underpinnings of disease onset and progression in genetic ALS variants: from presymptomatic to symptomatic disease stages.From1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- Measuring brain activation non-invasively in freely moving healthy and neuropsychiatric human populations using functional near-infrared spectroscopy (fNIRS)From1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- A multi-modal approach to study C9orf72-mediated diseaseFrom16 May 2022 → 15 May 2023Funding: BOF - postdoctoral mandates
Publications
1 - 10 of 21
- TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Authors: Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht, Michel Koole, Dietmar Thal, Philip Van Damme, Guy Bormans, Koen Van Laere
Pages: 604 - 607 - SUICIDALITY AMONG HEALTHCARE PROFESSIONALS DURING THE FIRST COVID19 WAVE
Authors: Ronny Bruffaerts, Leontien Jansen, Joke De Vocht
Pages: 66 - 70 - Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations
Authors: Joke De Vocht, Fouke Ombelet, Pegah Masrori, Hilde Van Esch, Michel Koole, Patrick Dupont, Koen Van Laere, Philip Van Damme
- Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis.
Authors: Pegah Masrori, Maxim De Schaepdryver, Joke De Vocht, Koen Poesen, Philip Van Damme
Pages: 1 - 2 - Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands
Authors: Donatienne Van Weehaeghe, Joke De Vocht, Michel Koole, Ahmadreza Rezaei, Georg Schramm, Philip Van Damme, Koen Van Laere
Pages: 1621 - 1627 - Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes
Authors: Martijn Devrome, Donatienne Van Weehaeghe, Joke De Vocht, Philip Van Damme, Koen Van Laere, Michel Koole
- Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
Authors: Benjamin Gille, Maxim De Schaepdryver, Janne Goossens, Lieselot Dedeene, Joke De Vocht, Emanuela Oldoni, An Goris, Ludo Van Den Bosch, Bart Depreitere, Kristl Claeys, et al.
Pages: 291 - 304 - Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy
Authors: Akila Weerasekera, Ronald Peeters, Diana Sima, Tom Dresselaers, Stefan Sunaert, Joke De Vocht, Kristl Claeys, Sabine Van Huffel, Philip Van Damme, Uwe Himmelreich
Pages: 22 - 31 - HDAC6 distribution in amyotrophic laterals sclerosis
Authors: Michel Koole, Joke De Vocht, Philip Van Damme, Koen Van Laere
Pages: S96 - S97 - Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen
Authors: Joke De Vocht, Philip Van Damme
Pages: 19 - 27